Skip to content
10-Q

Quarterly Report

TFF PHARMACEUTICALS, INC.

0001213900-24-068964

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 12, 2024 3.47M sh
Shares Diluted Q2 2024 · Jun 30, 2024 3.67M sh
Shares Diluted Q2 2024 · Jun 30, 2024 3.03M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 1.45M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 1.45M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$6.4M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$8.82M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $4.39M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $5.48M
Stockholders Equity Q2 2024 · Jun 30, 2024 $5.88M
Stockholders Equity Q2 2024 · Mar 31, 2024 $5.3M
Stockholders Equity Q2 2024 · Dec 31, 2023 $9.57M
Stockholders Equity Q2 2024 · Jun 30, 2023 $12.28M
Stockholders Equity Q2 2024 · Mar 31, 2023 $16.54M
Stockholders Equity Q2 2024 · Dec 31, 2022 $22.88M
Current Liabilities Q2 2024 · Jun 30, 2024 $3.62M
Current Liabilities Q2 2024 · Dec 31, 2023 $2.43M
Total Liabilities Q2 2024 · Jun 30, 2024 $3.62M
Total Liabilities Q2 2024 · Dec 31, 2023 $2.46M
Current Assets Q2 2024 · Jun 30, 2024 $5.88M
Current Assets Q2 2024 · Dec 31, 2023 $7.59M
Total Assets Q2 2024 · Jun 30, 2024 $9.5M
Total Assets Q2 2024 · Dec 31, 2023 $12.03M
Eps Diluted Q2 2024 · Jun 30, 2024 −$1.22
Eps Diluted Q2 2024 · Jun 30, 2024 −$3.37
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$3.47
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$8.34
Eps Basic Q2 2024 · Jun 30, 2024 −$1.22
Eps Basic Q2 2024 · Jun 30, 2024 −$3.37
Eps Basic restated Q2 2024 · Jun 30, 2023 −$3.47
Eps Basic restated Q2 2024 · Jun 30, 2023 −$8.34
Sga Expense Q2 2024 · Jun 30, 2024 $2.02M
Sga Expense Q2 2024 · Jun 30, 2024 $4.46M
Sga Expense Q2 2024 · Jun 30, 2023 $2.67M
Sga Expense Q2 2024 · Jun 30, 2023 $5.79M
Rd Expense Q2 2024 · Jun 30, 2024 $2.59M
Rd Expense Q2 2024 · Jun 30, 2024 $6.14M
Rd Expense Q2 2024 · Jun 30, 2023 $2.68M
Rd Expense Q2 2024 · Jun 30, 2023 $6.7M
Net Income Q2 2024 · Jun 30, 2024 −$4.48M
Net Income Q2 2024 · Jun 30, 2024 −$10.21M
Net Income Q2 2024 · Mar 31, 2024 −$5.74M
Net Income Q2 2024 · Jun 30, 2023 −$5.02M
Net Income Q2 2024 · Jun 30, 2023 −$12.07M
Net Income Q2 2024 · Mar 31, 2023 −$7.05M
Operating Income Q2 2024 · Jun 30, 2024 −$3.96M
Operating Income Q2 2024 · Jun 30, 2024 −$9.75M
Operating Income Q2 2024 · Jun 30, 2023 −$5.02M
Operating Income Q2 2024 · Jun 30, 2023 −$12.11M
Revenue Q2 2024 · Jun 30, 2024 $650.22K
Revenue Q2 2024 · Jun 30, 2024 $853.5K
Revenue Q2 2024 · Jun 30, 2023 $333.35K
Revenue Q2 2024 · Jun 30, 2023 $384.78K
Capex Q2 2024 · Jun 30, 2023 $35.71K